Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial

被引：0
|
作者：
Jingjing Wu
Lingling Duan
Lei Zhang
Zhenchang Sun
Xiaorui Fu
Xin Li
Ling Li
Xinhua Wang
Xudong Zhang
Zhaoming Li
Hui Yu
Yu Chang
Feifei Nan
Jiaqin Yan
Li Tian
Xiaoli Wang
Mingzhi Zhang
机构：
[1] The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Lymphoma Diagnosis and Treatment Centre of Henan Province
来源：
Journal of Neuro-Oncology | 2018年 / 140卷
关键词：
Teniposide; Methotrexate; Primary CNS lymphoma; Chemotherapy; Whole-brain radiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：427 / 434
页数：7
相关论文
共 50 条
  • [41] High-dose methotrexate and rituximab induction regimen in immunocompetent patients with primary CNS lymphoma: a retrospective single-center study of survival predictors
    DeAtkine, Andrew B.
    Abdelrashid, Moaaz
    Tucker, Zach
    Mehta, Amitkumar
    Markert, James M.
    Kim, Jinsuh
    Fiveash, John B.
    Oster, Robert A.
    Lobbous, Mina
    Nabors, L. Burt
    JOURNAL OF NEURO-ONCOLOGY, 2022, 158 (01) : 33 - 40
  • [42] R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma
    Omuro, Antonio
    Correa, Denise D.
    DeAngelis, Lisa M.
    Moskowitz, Craig H.
    Matasar, Matthew J.
    Kaley, Thomas J.
    Gavrilovic, Igor T.
    Nolan, Craig
    Pentsova, Elena
    Grommes, Christian C.
    Panageas, Katherine S.
    Baser, Raymond E.
    Faivre, Geraldine
    Abrey, Lauren E.
    Sauter, Craig S.
    BLOOD, 2015, 125 (09) : 1403 - 1410
  • [43] Phase II trial of temozolomide plus concurrent whole-brain radiation followed by TNV regimen as adjuvant therapy for patients with newly diagnosed primary CNS lymphoma
    Wang, Yong
    Liu, Baoyan
    Xu, Dezhi
    Zhao, Haitao
    Zhu, Yufang
    Xu, Jun
    Tao, Rongjie
    NEUROLOGY INDIA, 2013, 61 (03) : 260 - 264
  • [44] Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy
    Chiesa, Silvia
    Hohaus, Stefan
    Falcinelli, Lorenzo
    D'Alo, Francesco
    Martelli, Massimo Fabrizio
    Manfrida, Stefania
    Bartoli, Francesco Beghella
    Colosimo, Cesare
    Valentini, Vincenzo
    Aristei, Cynthia
    Balducci, Mario
    ANNALS OF HEMATOLOGY, 2020, 99 (10) : 2367 - 2375
  • [45] High-Dose Methotrexate and Cytarabine-Based multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement
    Umino, Kento
    Fujiwara, Shin-ichiro
    Sato, Kazuya
    Minakata, Daisuke
    Nakano, Hirofumi
    Yamasaki, Ryoko
    Kawasaki, Yasufumi
    Sugimoto, Miyuki
    Yamamoto, Chihiro
    Hatano, Kaoru
    Okazuka, Kiyoshi
    Oh, Lekuni
    Ohmine, Ken
    Suzuki, Takahiro
    Muroi, Kazuo
    Kanda, Yoshinobu
    ACTA HAEMATOLOGICA, 2017, 137 (02) : 93 - 99
  • [46] Phase 2 Trial of High-Dose Rituximab With High-Dose Cytarabine Mobilization Therapy and High-Dose Thiotepa, Busulfan, and Cyclophosphamide Autologous Stem Cell Transplantation in Patients With Central Nervous System Involvement by Non-Hodgkin Lymphoma
    Chen, Yi-Bin
    Batchelor, Tracy
    Li, Shuli
    Hochberg, Ephraim
    Brezina, Mark
    Jones, Sooae
    Del Rio, Candice
    Curtis, Morgan
    Ballen, Karen K.
    Barnes, Jeffrey
    Chi, Andrew S.
    Dietrich, Jorg
    Driscoll, Jessica
    Gertsner, Elizabeth R.
    Hochberg, Fred
    LaCasce, Ann S.
    McAfee, Steven L.
    Spitzer, Thomas R.
    Nayak, Lakshmi
    Armand, Philippe
    CANCER, 2015, 121 (02) : 226 - 233
  • [47] Improvement of outcomes of an escalated high-dose methotrexate-based regimen for patients with newly diagnosed primary central nervous system lymphoma: a real-world cohort study
    Li, Qing
    Ma, Jingjing
    Ma, Yan
    Lin, Zhiguang
    Kang, Hui
    Chen, Bobin
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 6115 - 6122
  • [48] Proliferation Predicts Failure-free Survival in Mantle Cell Lymphoma Patients Treated With Rituximab Plus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine
    Garcia, Mar
    Romaguera, Jorge E.
    Inamdar, Kedar V.
    Rassidakis, George Z.
    Medeiros, L. Jeffrey
    CANCER, 2009, 115 (05) : 1041 - 1048
  • [49] Methotrexate elimination and toxicity: MTHFR 677C>T polymorphism in patients with primary CNS lymphoma treated with high-dose methotrexate
    Choi, Yun Jung
    Park, Hyangmin
    Lee, Ji Sung
    Lee, Ju-Yeon
    Kim, Shin
    Kim, Tae Won
    Park, Jung Sun
    Kim, Jeong Eun
    Yoon, Dok Hyun
    Suh, Cheolwon
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) : 504 - 509
  • [50] Primary mediastinal large B-cell lymphoma: Outcome of a series of pediatric patients treated with high-dose methotrexate and cytarabine plus anti-CD20
    Pillon, Marta
    Carraro, E.
    Mussolin, L.
    Conter, V.
    Tondo, A.
    Arico, M.
    Mura, R.
    Sala, A.
    Vinti, L.
    Buffardi, S.
    Pierani, P.
    d'Amore, E. S. G.
    Basso, G.
    PEDIATRIC BLOOD & CANCER, 2018, 65 (02)
12345